blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3965792

EP3965792 - HMGB1 ANTAGONIST [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  11.02.2022
Database last updated on 14.09.2024
FormerThe international publication has been made
Status updated on  14.11.2020
Most recent event   Tooltip13.03.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
The Feinstein Institutes for Medical Research
350 Community Drive
Manhasset, NY 11030 / US
[2022/11]
Inventor(s)01 / AL-ABED, Yousef
350 Community Drive Manhasset
NY 11030 / US
02 / YANG, Huan
350 Community Drive Manhasset
NY 11030 / US
 [2022/11]
Representative(s)Michalski Hüttermann & Partner Patentanwälte mbB
Kaistraße 16A
40221 Düsseldorf / DE
[N/P]
Former [2022/11]Michalski Hüttermann & Partner Patentanwälte mbB
Speditionstraße 21
40221 Düsseldorf / DE
Application number, filing date20802214.508.05.2020
[2022/11]
WO2020US32025
Priority number, dateUS201962845568P09.05.2019         Original published format: US 201962845568 P
US201962845576P09.05.2019         Original published format: US 201962845576 P
US201962845578P09.05.2019         Original published format: US 201962845578 P
[2022/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020227603
Date:12.11.2020
Language:EN
[2020/46]
Type: A1 Application with search report 
No.:EP3965792
Date:16.03.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 12.11.2020 takes the place of the publication of the European patent application.
[2022/11]
Search report(s)International search report - published on:US12.11.2020
(Supplementary) European search report - dispatched on:EP19.12.2022
ClassificationIPC:A61K38/07, A61K31/7024, A61P29/00
[2022/11]
CPC:
A61P25/02 (EP,IL,US); A61K38/17 (EP,IL,US); A61K31/197 (EP,IL,US);
A61K38/00 (EP,IL,US); A61K38/07 (IL,US); A61K47/10 (IL,US);
A61K47/20 (EP,IL); A61K47/26 (IL,US); A61K47/65 (IL,US);
A61K9/0014 (IL,US); A61K9/0019 (EP,IL,US); A61K9/0043 (IL,US);
A61K9/0053 (IL,US); A61K9/007 (IL,US); A61K9/08 (EP,IL,US);
C07K1/113 (IL,US); C07K14/4703 (IL,US); C07K5/06069 (EP,IL);
C07K5/1016 (EP,IL,US); Y02A50/30 (EP,IL) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/11]
TitleGerman:HMGB1-ANTAGONIST[2022/11]
English:HMGB1 ANTAGONIST[2022/11]
French:ANTAGONISTE DE HMGB1[2022/11]
Entry into regional phase27.10.2021National basic fee paid 
27.10.2021Search fee paid 
27.10.2021Designation fee(s) paid 
27.10.2021Examination fee paid 
Examination procedure27.10.2021Examination requested  [2022/11]
06.07.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
16.03.2022Renewal fee patent year 03
30.03.2023Renewal fee patent year 04
13.03.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2016094899  (THE FEINSTEIN INST MEDICAL RES [US]);
International search[A]US9186371  (TANIGUCHI TADATSUGU [JP], et al);
 [A]WO2016094899  (THE FEINSTEIN INST MEDICAL RES [US]);
 [A]US2018344808  (TRACEY KEVIN J [US], et al);
by applicantUS4160452
 US4256108
 US4265874
 WO9011757
 US5007790
 WO9318755
 US5582837
 WO9747285
 WO9811879
 WO9855107
 US5972389
 WO0132217
 WO0156544
 WO0197783
 US6340475
 WO0232416
 US2002051820
 US6451808
 US6488962
 WO02096404
 US2003039688
 US2003044466
 WO03035041
 WO03035040
 WO03035029
 WO03035177
 WO03035039
 US2003104062
 US2003104053
 US2003147952
 US8138141
 US19680628455
 US19760628455
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.